Teladoc Health, Inc. (TDOC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 900M 1.8B 2.7B Q3 '24: 2.6B Q4 '24: 2.6B Q1 '25: 2.6B Q2 '25: 2.5B Q3 '25: 2.5B Q4 '25: 2.5B Q1 '26: 2.5B Q2 '26: 2.5B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q2 '17: 118M Q3 '17: 144.6M Q4 '17: 171.7M Q1 '18: 203.7M Q2 '18: 236M Q3 '18: 260.9M Q4 '18: 289.2M Q1 '19: 310.3M Q2 '17 Q3 '17 Q4 '17 Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19

Operating Income TTM

-1.2B -800M -400M 0 400M 800M 1.2B Q3 '24: -1B Q4 '24: -1B Q1 '25: -1.1B Q2 '25: -267.6M Q3 '25: -275.2M Q4 '25: -263M Q1 '26: -204.1M Q2 '26: -186.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-1.1B -700M -350M 0 350M 700M 1.1B Q3 '24: -981.7M Q4 '24: -1B Q1 '25: -1B Q2 '25: -207.4M Q3 '25: -223.6M Q4 '25: -200.3M Q1 '26: -171.1M Q2 '26: -177.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 300M 600M 900M Q3 '24: 755.8M Q4 '24: 751.3M Q1 '25: 753.6M Q2 '25: 756M Q3 '25: 763.5M Q4 '25: 771.6M Q1 '26: 772.3M Q2 '26: 772.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 150M 300M 450M Q3 '24: 337.9M Q4 '24: 293.7M Q1 '25: 300.7M Q2 '25: 303.4M Q3 '25: 292.5M Q4 '25: 294.4M Q1 '26: 288M Q2 '26: 261.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

0 150M 300M 450M Q3 '24: 331.8M Q4 '24: 282.9M Q1 '25: 288.3M Q2 '25: 291.7M Q3 '25: 280.1M Q4 '25: 285.5M Q1 '26: 280.1M Q2 '26: 253.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '24: 167.7M Q2 '24: 170.2M Q3 '24: 171.5M Q1 '25: 174.2M Q2 '25: 175.9M Q3 '25: 176.9M Q1 '26: 179.1M Q2 '26: 181M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '24: -5.77 Q4 '24: -5.86 Q1 '25: -5.90 Q2 '25: -1.17 Q3 '25: -1.26 Q4 '25: -1.14 Q1 '26: -0.97 Q2 '26: -0.99 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.